R. Louie

Treatment of Acute Myelogenous Leukemia (non-APL) with Intravenous Trisenox® (Arsenic Trioxide) and Ascorbic Acid: Preliminary Results.

A. Levine, D. Douer, I. Weitz, 2004 .

CAR+ and CAR- T cells differentiate into an NK-like subset that is associated with increased inflammatory cytokines following infusion

R. Balderas, I. Deveson, F. Luciani, 2022, medRxiv.

Detection of IgG‐Associated Determinants in Reduced and Alkylated Preparations of Human IgG3 by Monoclonal Antibodies

C. Reimer, M. Dumas, R. Harmon, 1984, Vox sanguinis.

Efficacy and safety of melphalan, arsenic trioxide and ascorbic acid combination therapy in patients with relapsed or refractory multiple myeloma: a prospective, multicentre, phase II, single‐arm study

R. Moss, J. Lutzky, Siu-Fun Wong, 2006, British journal of haematology.

Arsenic Trioxide in Multiple Myeloma: Rationale and Future Directions

S. Waxman, L. Boise, K. Anderson, 2002, Cancer journal.

Interaction Between the Soluble Antigen of PR8 and NWS Virus.∗

R. Louie, J. Fong, 1964, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

The E ffec ts of Higher Education Endowment Management Practices on Endowment Performance

R. Louie, Stanton McElhaney, 2010 .